Sandy Beare
Impact in
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- John Bridgewater (14 shared papers)Harpreet Wasan (10 shared papers)Juan W. Valle (7 shared papers)Mark Jitlal (7 shared papers)Junji Furuse (2 shared papers)Takuji Okusaka (2 shared papers)Nobumasa Mizuno (2 shared papers)David Cunningham (6 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)British Journal of Cancer (4 papers)Annals of Oncology (3 papers)The Lancet Oncology (3 papers)BMC Cancer (2 papers)
- Partner nations
- United KingdomAustriaJapan
In The Last Decade
Sandy Beare
30 papers receiving 1.4k citations
Sandy Beare's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 510
- Hepatology 130
- Surgery 696
- Pulmonary and Respiratory Medicine 481
- Pathology and Forensic Medicine 123
Countries citing papers authored by Sandy Beare
This map shows the geographic impact of Sandy Beare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Beare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Beare more than expected).
Fields of papers citing papers by Sandy Beare
This network shows the impact of papers produced by Sandy Beare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Beare. The network helps show where Sandy Beare may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandy Beare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial Hit paper breakdown → | 2017 | 345 |
| 2 | 2013 | 273 | |
| 3 | 2015 | 198 | |
| 4 | 2013 | 113 | |
| 5 | 2017 | 99 | |
| 6 | 2002 | 59 | |
| 7 | 2019 | 52 | |
| 8 | 2014 | 36 | |
| 9 | 2017 | 29 | |
| 10 | 2018 | 27 | |
| 11 | 2015 | 25 | |
| 12 | 2018 | 22 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 18 | |
| 15 | 2017 | 18 | |
| 16 | 2019 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2009 | 8 | |
| 19 | 2019 | 6 | |
| 20 | 2013 | 6 |
About Sandy Beare
Sandy Beare is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Colorectal Cancer Treatments and Studies (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Advanced Radiotherapy Techniques (2 papers), Cancer Genomics and Diagnostics (2 papers) and Management of metastatic bone disease (2 papers). The work is most often cited by research in Oncology (510 citations), Hepatology (130 citations), Surgery (696 citations), Pulmonary and Respiratory Medicine (481 citations) and Pathology and Forensic Medicine (123 citations). Sandy Beare has collaborated with scholars based in United Kingdom, Austria and Japan. Frequent co-authors include John Bridgewater, Harpreet Wasan, Juan W. Valle, Mark Jitlal, Junji Furuse, Takuji Okusaka, Nobumasa Mizuno, David Cunningham, Sharon Forsyth and Andre Lopes. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, The Lancet Oncology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.